ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Antibodies"

  • 2019 American Transplant Congress

    Use of Anti-Vimentin Antibodies as a Possible Marker for Graft Dysfunction Following Renal Transplant, a Prospective Study

    E. Acosta1, T. Divanyan1, D. Patel1, F. Jourd'heuil2, D. Jourd'heuil2, R. Lopez-Soler3

    1Albany Medical College, Albany, NY, 2Molecular and Cellular Physiology, Albany Medical College, Albany, NY, 3Surgery, Section of Transplantation, Albany Medical College, Albany, NY

    *Purpose: In our previously published work, we showed that presence of anti-vimentin antibodies (AVA) after renal transplant correlated with early IFTA (Interstitial Fibrosis and Tubular…
  • 2019 American Transplant Congress

    Ex-vivo Xenoperfusion Of Wild Type And Galtko.hcd55 Pig Livers With Human Whole Blood

    D. Detelich, C. Rickert, C. Eymard, C. Carroll, S. Kimura, H. Yeh, J. Markmann

    Massachusetts General Hospital, Boston, MA

    *Purpose: Pig-to-human liver xenotransplantation is not currently feasible due to rapid and profound thrombocytopenia, coagulopathy and hyperacute rejection. Successful development of genetically modified swine to…
  • 2019 American Transplant Congress

    Investigation and Regulation of Induced Anti-Pig Antibody Production in GTKO Pig-to-Cynomolgus Monkey Artery Retransplantation

    S. Hurh1, E. Lee1, J. Jeong2, G. Lee1, S. Park1, S. Ahn3, S. Min3, C. Ahn4

    1Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea, Republic of, 2Department of Nephrology, Ajou University School of Medicine, Suwon, Korea, Republic of, 3Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of, 4Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of

    *Purpose: Although the recent progress in xenograft survival in pig-to-nonhuman primate heart and kidney transplantation, little is known about retransplantation in pig antigen-sensitized recipient. This…
  • 2019 American Transplant Congress

    Prognostic Value of C3d Fixing Preformed Donor-Specific Antibody in Crossmatch-Positive Living Kidney Transplantation

    K. Miyake1, M. Okumi1, Y. Kakuta1, K. Unagami2, M. Furusawa1, H. Ishida2, K. Tanabe1

    1Urology, Tokyo Women's Medical University, Sinjuku, Japan, 2Organ Transplant Medicine, Tokyo Women's Medical University, Sinjuku, Japan

    *Purpose: The occurrence of acute antibody-mediated rejection (ABMR) was higher in flow cytometric crossmatch (FCXM)-positive patients despite desensitization, and complement binding ability of donor specific…
  • 2019 American Transplant Congress

    Identification of Antibodies Reactive to Vimentin in a Rat Kidney Transplant Model of Chronic Antibody-Mediated Rejection

    S. Reese, N. Wilson, L. Ptak, J. Sullivan, W. Burlingham, A. Djamali, S. E. Panzer

    University of Wisconsin Madison, Madison, WI

    *Purpose: As many as 30% of patients with chronic active antibody-mediated rejection (cAMR) lack HLA-specific antibodies. Recently, researchers identified clinical relevance of non-HLA antibodies, including…
  • 2019 American Transplant Congress

    Gene Expression Profiling for Cardiac Transplant Recipients: Results from the Outcomes AlloMap® Registry

    S. Hall1, G. Ewald2, P. Berman3, A. Kao4, T. Wolf-Doty5, J. Yee5, J. Kobashigawa6

    1Baylor University Medical Center, Dallas, TX, 2Washington University, St. Louis, MO, 3Tampa General Hospital, Tampa, FL, 4Saint Luke's Mid America Heart Institute, Kansas City, MO, 5CareDx, Brisbane, CA, 6Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: Transplant registries may facilitate collection of comprehensive and unbiased real-world data on short and long-term outcomes of patients. We share the results of patients…
  • 2019 American Transplant Congress

    Is Pre-transplant Plasmapheresis For Patients With Insignificant Abo Blood Type Antibody In Abo Blood Type Incompatible Kidney Transplant Necessary? – A Japanese Single Center Study.

    M. Miyazaki, A. Mitsuke, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Seki, H. Harada

    Urology and Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Hokkaido, Japan

    *Purpose: ABO incompatible kidney donor (ABOiKT) is still precious to fill up the extremely organ donor shortages in our country. Though plasmaphresis (PP) as desensitization…
  • 2019 American Transplant Congress

    Erythropoietin Ameliorates Parent to F1 Murine Graft versus Host Disease by Inhibiting TFH

    A. Angeletti1, C. Donadei1, A. Cumpelik1, C. Cantarelli1, C. Guglielmo1, G. La Manna2, P. Heeger1, P. Cravedi1

    1Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 2Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (DIMES), Policlinico Sant'Orsola-Malpighi, Bologna, Italy

    *Purpose: Building upon our previously generated evidence that erythropoietin (EPO) directly inhibits effector T cells (JASN 2015, 2017) and reduces autoantibody formation in murine lupus,…
  • 2019 American Transplant Congress

    Natural Antibodies and Left Ventricular Assist Device Complications

    S. B. See1, A. Pinsino2, R. Shihab1, N. Kunimune1, D. Onat2, E. Hittesdorf3, A. R. Garan2, V. K. Topkara2, Y. Naka4, H. Takayama4, K. Takeda4, P. Colombo2, M. Yuzefpolskaya2, G. Wagener3, E. Zorn1

    1Columbia Center for Translational Immunology, Columbia University, New York, NY, 2Division of Cardiology, Columbia University, New York, NY, 3Department of Anesthesiology, Columbia University, New York, NY, 4Department of Surgery, Columbia University, New York, NY

    *Purpose: Left ventricular assist devices (LVAD) are used as a bridge to heart transplantation or destination therapy for advanced heart failure. For all its benefits,…
  • 2019 American Transplant Congress

    5-Year Post-Transplant Outcomes with Bortezomib-Based Desensitization in Renal Transplant Recipients

    K. Zheng1, S. Tremblay1, A. R. Shields2, M. A. Cardi2, J. Kremer2, R. R. Alloway1, E. S. Woodle1

    1U of Cincinnati, Cincinnati, OH, 2Christ Hospital, Cincinnati, OH

    *Purpose: Renal transplant (RT) after desensitization (DS) has been associated with increased rejection rates. Proteasome inhibitor(PI)-based DS yields significant reductions in HLA Ab among sensitized…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 57
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences